Johnson & Johnson income statement & cash flow
In the fiscal year ended Dec 28, 2025, Johnson & Johnson reported net income of $26.80B on revenue of $94.19B. Operating cash flow was $24.53B and capital expenditures were $4.83B, leaving $19.70B of free cash flow (operating cash flow minus capital expenditures).
Income statement and cash flow summary
| Fiscal year ended | Jan 2017 | Dec 2017 | Dec 2018 | Dec 2019 | Jan 2021 | Jan 2022 | Jan 2023 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71.89B | $76.45B | $81.58B | $82.06B | $82.58B | $78.74B | $79.99B | $85.16B | $88.82B | $94.19B |
| Gross profit | $50.10B | $51.01B | $54.49B | $54.50B | $54.16B | $55.34B | $55.39B | $58.61B | $61.35B | $63.94B |
| Net income | $16.54B | $1.30B | $15.30B | $15.12B | $14.71B | $20.88B | $17.94B | $35.15B | $14.07B | $26.80B |
| Diluted EPS | $5.93 | $0.47 | $5.61 | $5.63 | $5.51 | $7.81 | $6.73 | $13.72 | $5.79 | $11.03 |
| Operating cash flow | $18.77B | $21.06B | $22.20B | $23.42B | $23.54B | $23.41B | $21.19B | $22.79B | $24.27B | $24.53B |
| Capital expenditures | $3.23B | $3.28B | $3.67B | $3.50B | $3.35B | $3.65B | $4.01B | $4.54B | $4.42B | $4.83B |
| Reported in | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 | 10-K 2026 |
Margins
Each figure divided by revenue for the same fiscal year.
| Fiscal year ended | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| Dec 2025 | 67.9% | — | 28.5% |
| Dec 2024 | 69.1% | — | 15.8% |
| Dec 2023 | 68.8% | — | 41.3% |
| Jan 2023 | 69.3% | — | 22.4% |
| Jan 2022 | 70.3% | — | 26.5% |
Source: SEC EDGAR XBRL company facts for CIK 200406 (raw data). Most recent filing in this dataset: 10-Q filed Oct 21, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.